Labco to swallow €440m of IPO proceeds
Labco, the French medical diagnostics firm, is set to price its IPO at or near the bottom of the original range, to raise about €440m of primary and secondary proceeds.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: